Jane Street’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Jane Street’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-57,572	Closed	-$50K	–	6124
2019 Q2	$50K	Buy	+57,572	New	+$90.1K	﹤0.01%	4956
2018 Q4	–	Sell	-12,292	Closed	-$182K	–	6134
2018 Q3	$182K	Buy	+12,292	New	+$195K	﹤0.01%	4726

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Jane Street's SNNA Position: Q3 2019 in Review

Jane Street sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2019, closing a stake of 57,572 shares — an estimated $50K sold.

Jane Street first reported a position in SNNA in Q3 2018 and held it in 2 quarters. The position peaked at $182K in Q3 2018. 23 funds tracked by Wall St. Rank hold SNNA as of Q3 2019.

Jane Street reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Jane Street sold 57,572 Sienna Biopharmaceuticals, Inc. shares in Q3 2019, an estimated $50K.
Jane Street first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2018 and held it in 2 quarters.
Jane Street's Sienna Biopharmaceuticals, Inc. position peaked at $182K in Q3 2018.
23 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.